Bristol-Myers Squibb Co.

BMY NYS
Pharmaceuticals
New York, NY
2016 Revenue (US$ Millions)$19,427
Revenue Growth (%)17.31%
2015 Revenue (US$ Millions)$16,560
Net Income (US$ Millions)$4,457
Common Shares Outstanding (Millions)1,664.00
Earnings Per Share (US$)$2.65
Price to Earnings Ratio28.75
Total Equity (US$ Millions)$16,177
Return on Equity (%)31.24%
Long Term Debt (US$ Millions)$5,716
Debt to Equity Ratio (%)0.35%
Market Capitalization (US$ Millions)$97,244
Total Assets (US$ Millions)$33,707
Current Assets (US$ Millions)$13,704
Inventories (US$ Millions)$1,241
Current Liabilities (US$ Millions)$8,841
Cost Of Goods Sold (US$ Millions)$4,946
Asset Turnover0.59
Inventory Turnover4.02